DR. PRADEEP Y RAMULU MD
Prescription History 1003821521
Ophthalmology in Baltimore, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PRADEEP Y RAMULU MD, an active Ophthalmology specialist practicing in Baltimore, MD. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,802 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 502 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Latanoprost | 502 | $15.90 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 502 Medicare prescriptions for Latanoprost, about 3.7 times the volume of the typical Maryland prescriber of this medication (136.4). Medicare paid an average of $15.90 per fill, versus $14.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,233.7 30-Day Fills standardized to 30-day supplies 36,639 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 316 | $23.74 | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 316 Medicare prescriptions for Dorzolamide-Timolol, about 3.2 times the volume of the typical Maryland prescriber of this medication (97.8). Medicare paid an average of $23.74 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 804.4 30-Day Fills standardized to 30-day supplies 24,131 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 223 | $35.95▼ below MD avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 223 Medicare prescriptions for Brimonidine Tartrate, about 3.4 times the volume of the typical Maryland prescriber of this medication (64.9). Medicare paid an average of $35.95 per fill, versus $48.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 538.6 30-Day Fills standardized to 30-day supplies 16,031 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 153 | $10.92▼ below MD avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 153 Medicare prescriptions for Timolol Maleate, about 2 times the volume of the typical Maryland prescriber of this medication (78.2). Medicare paid an average of $10.92 per fill, versus $22.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 425 30-Day Fills standardized to 30-day supplies 12,721 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 106 | $49.34 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 106 Medicare prescriptions for Prednisolone Acetate, about the same volume as the typical Maryland prescriber of this medication (97.8). Medicare paid an average of $49.34 per fill, versus $45.04 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 191.6 30-Day Fills standardized to 30-day supplies 5,388 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 63 | $20.35▼ below MD avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 63 Medicare prescriptions for Dorzolamide Hcl, about 1.4 times the volume of the typical Maryland prescriber of this medication (45.9). Medicare paid an average of $20.35 per fill, versus $21.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 137.2 30-Day Fills standardized to 30-day supplies 3,955 Days of Medication total across all patients in 2024 | |||
| RhopressaNetarsudil Mesylate | 59 | $589.13 | ▲ More than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. A Rho kinase inhibitor with norepinephrine transport inhibitory activity that reduces production of aqueous humor. In 2024, this provider wrote 59 Medicare prescriptions for Rhopressa, about 1.4 times the volume of the typical Maryland prescriber of this medication (40.8). Medicare paid an average of $589.13 per fill, versus $570.68 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 111.9 30-Day Fills standardized to 30-day supplies 3,306 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 54 | $566.57▼ below MD avg | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 54 Medicare prescriptions for Lumigan, about the same volume as the typical Maryland prescriber of this medication (57.2). Medicare paid an average of $566.57 per fill, versus $577.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 121 30-Day Fills standardized to 30-day supplies 3,565 Days of Medication total across all patients in 2024 | |||
| Travoprost | 44 | $234.36 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 44 Medicare prescriptions for Travoprost, about 1.3 times the volume of the typical Maryland prescriber of this medication (34.2). Medicare paid an average of $234.36 per fill, versus $213.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96.2 30-Day Fills standardized to 30-day supplies 2,812 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 42 | $12.65▼ below MD avg | ▲ More than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 42 Medicare prescriptions for Erythromycin, about 1.3 times the volume of the typical Maryland prescriber of this medication (32.8). Medicare paid an average of $12.65 per fill, versus $13.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 44 30-Day Fills standardized to 30-day supplies 676 Days of Medication total across all patients in 2024 | |||
| Brinzolamide | 32 | $263.63 | ≈ Typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. An antiglaucoma agent. In 2024, this provider wrote 32 Medicare prescriptions for Brinzolamide, about the same volume as the typical Maryland prescriber of this medication (28.9). Medicare paid an average of $263.63 per fill, versus $223.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 86.5 30-Day Fills standardized to 30-day supplies 2,595 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 28 | $207.20 | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 28 Medicare prescriptions for Dorzolamide-Timolol, about the same volume as the typical Maryland prescriber of this medication (26). Medicare paid an average of $207.20 per fill, versus $169.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 74 30-Day Fills standardized to 30-day supplies 2,220 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 25 | $378.45 | ≈ Typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 25 Medicare prescriptions for Simbrinza, about 88% of the volume of the typical Maryland prescriber of this medication (28.5). Medicare paid an average of $378.45 per fill, versus $294.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58.7 30-Day Fills standardized to 30-day supplies 1,761 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 25 | $188.24 | ≈ Typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 25 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 83% of the volume of the typical Maryland prescriber of this medication (30). Medicare paid an average of $188.24 per fill, versus $175.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64.9 30-Day Fills standardized to 30-day supplies 1,948 Days of Medication total across all patients in 2024 | |||
| TafluprostTafluprost/Pf | 22 | $258.19 | ≈ Typical |
About Tafluprost: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2024, this provider wrote 22 Medicare prescriptions for Tafluprost, about 78% of the volume of the typical Maryland prescriber of this medication (28.3). Medicare paid an average of $258.19 per fill, versus $225.21 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.5 30-Day Fills standardized to 30-day supplies 1,605 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 18 | $596.69 | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 18 Medicare prescriptions for Combigan, about half the volume of the typical Maryland prescriber of this medication (34.2). Medicare paid an average of $596.69 per fill, versus $435.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.6 30-Day Fills standardized to 30-day supplies 1,604 Days of Medication total across all patients in 2024 | |||
| Alphagan PBrimonidine Tartrate | 15 | $314.99▼ below MD avg | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 15 Medicare prescriptions for Alphagan P, about 61% of the volume of the typical Maryland prescriber of this medication (24.7). Medicare paid an average of $314.99 per fill, versus $438.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 15 | $22.22 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 15 Medicare prescriptions for Ketorolac Tromethamine, about 19% of the volume of the typical Maryland prescriber of this medication (77.7). Medicare paid an average of $22.22 per fill, versus $21.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.3 30-Day Fills standardized to 30-day supplies 624 Days of Medication total across all patients in 2024 | |||
| Loteprednol Etabonate | 13 | $225.69 | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ It is also used after eye surgery. Loteprednol works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2024, this provider wrote 13 Medicare prescriptions for Loteprednol Etabonate, about half the volume of the typical Maryland prescriber of this medication (28.9). Medicare paid an average of $225.69 per fill, versus $168.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.8 30-Day Fills standardized to 30-day supplies 440 Days of Medication total across all patients in 2024 | |||
| Travatan ZTravoprost | 13 | $581.40▼ below MD avg | ≈ Typical |
About Travatan Z: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 13 Medicare prescriptions for Travatan Z, about 88% of the volume of the typical Maryland prescriber of this medication (14.8). Medicare paid an average of $581.40 per fill, versus $591.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 26.2 30-Day Fills standardized to 30-day supplies 784 Days of Medication total across all patients in 2024 | |||
| Difluprednate | 12 | $137.34 | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2024, this provider wrote 12 Medicare prescriptions for Difluprednate, about half the volume of the typical Maryland prescriber of this medication (27.3). Medicare paid an average of $137.34 per fill, versus $112.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 522 Days of Medication total across all patients in 2024 | |||
| Bromfenac Sodium | 11 | $506.06 | ▼ Less than typical |
About Bromfenac Sodium: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2024, this provider wrote 11 Medicare prescriptions for Bromfenac Sodium, about a third of the volume of the typical Maryland prescriber of this medication (34.6). Medicare paid an average of $506.06 per fill, versus $156.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 321 Days of Medication total across all patients in 2024 | |||
| VyzultaLatanoprostene Bunod | 11 | $515.16▼ below MD avg | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. A lanatoprost prodrug, nitric oxide donor, and PGF2alpha agonist. In 2024, this provider wrote 11 Medicare prescriptions for Vyzulta, about a third of the volume of the typical Maryland prescriber of this medication (33.6). Medicare paid an average of $515.16 per fill, versus $533.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 17.7 30-Day Fills standardized to 30-day supplies 517 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. PRADEEP Y RAMULU MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Baltimore, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
